Doctors: Cuba’s Coronavirus Miracle Cure ‘Harmful to

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
200
Doctors: Cuba’s Coronavirus Miracle Cure
‘Harmful to the Lives of Thousands Worldwide’
< >

GettyImages-1206754199-200x150.png

The human rights NGO Cuban Prisoners Defenders published an article on Friday citing three Cuban medical researchers who concluded that the communist regime’s publicity campaign for Interferon alpha-2b, which it claims can cure Chinese coronavirus, is a “serious crime against world public health.”

“When the Government of Cuba assures that the Interferon developed in Cuba cures the coronavirus, it is committing a serious crime against world public health, since this drug not only lacks any scientific proof, but also where it has been tested has already given null results of encouragement,” the doctors concluded, urging the World Health Organization (W.H.O.) to formally condemn the Cuban Communist Party for urging off-label use of a dangerous drug when no clinical trials or scientific confirmations exist that it works.

Interferons are “involved in alerting the cellular immune system to viral infection of host cells. Interferons not only exhibit important antiviral effects but also exert a key influence on the quality of the cellular immune responses and amplify antigen presentation to specific T cells.” A study published in 2004 in the Journal of Clinical Virology found that interferon-beta can “strongly” block multiplication of the Sudden Acute Respiratory Syndrome (SARS) virus, a type of coronavirus, in human cells, but that interferon-alpha and interferon-gamma did not appear to have the same effect.

The Wuhan coronavirus is believed to be closely related to the SARS coronavirus. Cuba has spent months promoting a domestically developed interferon – interferon-alpha 2b – as a successful antiviral against the Wuhan virus, offering little to no evidence.

The doctors writing the Cuban Prisoners Defenders article warn that the use of interferon-alpha can cause severe side effects in patients while potentially having no effect on the Chinese coronavirus.

“Eminent Cuban doctors who have helped to prepare this report have witnessed its use in the elderly hospitalized with severe, community and hospital pneumonia – now classified as associated with health care – and have attested to Prisoners Defenders of the null reduction in mortality,” the report reads. “The existence of the corresponding clinical trials that justify their use is also unknown.”

The doctors note that the Cuban Communist Party’s argument in favor of the drug is simply that many who have taken it have also survived a Chinese coronavirus infection, which they conclude is insufficient evidence for global use of a drug with severe side effects.

If we consider that most patients develop mild or uncomplicated forms of the disease – some without symptoms – around approx. 14% can present severe forms with the need to receive oxygen, and another approx. 5% may require admission to Intensive Care units, how is it possible to ensure that the good evolution of most patients is due to the use of Heberferon [the brand name for Cuban interferon-alpha 2b] and not to the natural course of the disease?

If there are no minimally serious scientific protocols, with a control group, that is, patients who do not receive this drug to compare the evolution with those who do, and even other placebo control groups, the results are more than questionable and are not minimally serious.

It does not have the minimum necessary to be considered a scientific investigation.

As interferon-alpha has been used to treat hepatitis, the report quotes a hepatologist, Edward Mena, who states that their use results in a “very strong and difficult treatment.”

“The side effects are like you’re in chemical therapy. Patients have nausea, vomiting, body pain, anemia; platelets, white blood cells are lowered … it is a very strong and difficult treatment. The side effects are many,” Mena reportedly said.

The drug could “kill, rather than cure patients,” the doctors say.

Granma, the official publication of the Cuban Communist Party, proclaimed in March that the Cuban interferon was showing “effectiveness in treating patients with the new SARS Cov-2 coronavirus.” It thanked Fidel Castro – a lawyer, not a virologist, by trade – for the “visionary thinking” that created the interferon and claimed that Cuban and Chinese scientists came up with the treatment together. Granma had previously stated that Cuba was somehow developing 22 drugs to fight coronavirus, none of them accepted as treatments for the Wuhan virus.

Interferon-alpha 2b’s use against coronavirus in Wuhan, where the virus originated, has become part of the Cuban state media lore about its success. Yet the doctors writing for Cuban Prisoners Defenders say “experts [in Wuhan] come to tell us to ‘try if you want, but we have tried it and we have not obtained evidence of its benefits.'”

Cuban Prisoners Defenders concludes that the “reckless and dangerous” use and promotion of the drug is an attempt by the Cuban government to enrich itself even further off of its medical businesses, the largest of which is its $11-billion-a-year slave doctor trade.

“Cuba generates from 2 to 6 times the national income of tourism through the “rent” in a state of slavery of doctors that are sent to more than 60 countries in the world,” the doctors write.

While no drug has received universal approval as a safe treatment for coronavirus, the use of interferon-beta – not the interferon Cuba is promoting – is part of a drug cocktail undergoing trials under the W.H.O.’s auspices. Testing has reportedly begun on the use of interferon-beta along with two antivirals, Science magazine reported in March. One of the researchers the magazine quoted warned, “if it is given late in the disease it could easily lead to worse tissue damage instead of helping patients.”

Cuba has documented 923 cases of Chinese coronavirus as of Friday; 31 people have died, according to the communist government.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 5

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 6

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Updated Category News Views 4

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading

Top 5 Most Recently Viewed Articles

SiriusXM CEO to Share Insights at Key Industry Conference

Updated Category News Views 186

SiriusXM CEO to Share Insights at Key Industry Conference SiriusXM (NASDAQ: SIRI) is set to make an impact at the upcoming Morgan Stanley Technology, Media and Telecom Conference. Scheduled for March 5, 2025, Jennifer Witz, the Chief Executive Officer of SiriusXM, will take the stage to discuss the company's journey and future prospects in the dynamic landscape of audio...

Continue Reading
Ardelyx Welcomes New Leaders to Strengthen Business Strategy

Updated Category News Views 156

Ardelyx Strengthens Leadership Team Ardelyx, Inc. (NASDAQ: ARDX), a pioneering biopharmaceutical company dedicated to developing innovative, first-in-class medicines that address significant unmet medical needs, has made significant changes to its leadership team. Recently, Mike Kelliher has been elevated to the position of Chief Business Officer, while James P. Brady...

Continue Reading
Whitestone REIT Welcomes Felice Terrigno as New Director in Texas

Updated Category News Views 142

Welcoming Felice Terrigno to Whitestone REIT Whitestone REIT (NYSE: WSR), a leading real estate investment trust focused on open-air shopping centers, is thrilled to announce the addition of Felice Terrigno as the Houston Division Director. This strategic hiring underlines the company's commitment to strengthening its leasing operations and enhancing its portfolio across...

Continue Reading
MEXC Enthusiastically Backs Solana Summit APAC 2025 Event

Updated Category News Views 122

MEXC to Act as a Key Sponsor for the Solana Summit APAC 2025 MEXC, a prominent name in the global cryptocurrency exchange landscape, is set to play an integral role as one of the major sponsors at the Solana Summit APAC 2025. This prestigious event is poised to highlight MEXC's ongoing commitment towards advancing the Solana ecosystem. Fostering Strategic Alliances in the...

Continue Reading
Fortuna Mining Corp. Reports Upcoming Financial Results Call

Updated Category News Views 44

Fortuna Mining Corp. Financial Results Announcement Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is set to announce its unaudited financial statements and Management's Discussion and Analysis (MD&A) for the third quarter. This much-anticipated news will be released after the market closes on a date in early November. Investors and analysts alike are keen to see how the...

Continue Reading